Introduction
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Periodontitis (gum disease) is a polymicrobial, chronic condition inflammatory disease of the 62 gingiva characterized by a progressive breakdown of gum tissue. If left untreated, periodontitis 63 results in a deterioration of the alveolar bone resulting in loosening and eventual loss of the tooth 64
(1,2). Oral microbiologists have determined that periodontal disease (PD) is caused by complex 65 biofilms that form at the tooth-gum interface. As the disease progresses, the biofilms become 66 more complex with the early colonizers being mostly commensal bacteria (e.g., Streptococcus 67
and Veillonella), and the later colonizers tending to be more pathogenic (e.g., Porphyromonas 68
and Treponema) (2-4). 69
Numerous studies have established risk factors for coronary artery disease including 70 smoking, obesity, diabetes, hypertension and hypercholesterolemia (5). In addition, a number of 71 studies over the past two decades have suggested an association between periodontitis infection 72 and cardiovascular disease (CVD) (6-9). A meta-analysis found a 44% increase in risk of future 73 cardiovascular disease in adults under age 65 with periodontal disease (10), while another study 74 found a clear association between chronic periodontitis and risk of coronary heart disease that 75 revealed a hazard ratio of 2, independent of all other cardiovascular risk factors (6). Another 76 study of endothelial function, a reliable indicator of vascular health, and serum inflammatory 77 markers in middle-aged men showed improvement of vascular function after aggressive 78 treatment of their periodontal disease (11). A 2007 meta-analysis by Bahekar et al. of cohort 79 studies, case-control studies and cross-sectional studies, found that individuals with PD had 80 between a 1.14 and 2.2 times greater risk of developing coronary heart disease (CHD) than those 81 without PD (12). 82 PD is hypothesized to contribute to atherosclerosis in two ways. First, the pathogens 83 causing periodontal disease may directly infect the atherosclerotic plaques. Direct studies of 84 atherosclerotic plaques have detected the presence of Porphyromonas gingivalis, Streptococcus 85 sanguis, and other major oral bacteria (13, 14) . However, this may represent secondary 86 colonization of pre-existing atherosclerotic plaques at sites of turbulent flow. Some studies have 87 also raised the possibility that bacterial invasion of the endothelium occurs and several studies 88 have documented periodontal pathogens present in atherosclerotic plaques (15, 16 However, because of its chronicity, this is thought to progress to systemic inflammation, and it 93 has been shown that patients with periodontitis have elevated levels of tumor necrosis factor-94 alpha (TNFα), interleukin 1 beta (IL-1β), C-reactive protein (CRP), interleukin 6 (IL-6), and 95 monocyte chemoattractant protein 1 (MCP-1/CCL2) (17-19). A 17.5 years follow-up study of 96 2549 individuals with major coronary heart disease and 3696 control subjects evaluated whether 97 CRP and other inflammatory markers could serve as biomarkers for CHD risk. The study 98 concluded that CRP is a moderate predictor for CHD (20). It is not clear whether the increase in 99 inflammatory cytokines represents a response to chronic local infection or to the presence of 100 bacteria (or bacterial fragments) circulating in the blood, but in either case, a systemic 101 inflammatory response is initiated. In this study, we used direct DNA extraction and metagenomic sequencing to explore the 121 relationship of periodontal biofilm bacteria to levels of systemic inflammation and vascular 122 dysfunction in an American Indian/Alaska Native (AI/AN) population in southern California. 123 AI/AN populations have a higher prevalence of both periodontal disease and heart disease than 124 the general population, making the potential connection between gum disease and heart disease 125 an important subject of study for this population. This study builds upon our previous amplicon-126 based 16S ribosomal RNA marker gene study, which focused solely on periodontal disease. 
Results and discussion
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Table 1 details the general characteristics of the population whose periodontal biofilms were 231 analyzed in this study. Our metagenomic analysis of serum cytokines and periodontal pathogens 232 uncovered a statistically significant relationship between the relative abundance of four primary 233 periodontal pathogens and IL-1 (Pearson correlation; r=0.64, p=0.0008, p(adj)=0.006; Table 2 ). 234
We also discovered a positive relationship with IFNγ, but the association was not significant post 235 correction (r=0.42, p=0.039, p(adj)=0.27; Table 2 ). These findings are somewhat in contrast to 236 the correlations between cytokine levels and measure of PPD in a parallel study of the same 237
population. Delange et al. (in review)
found an association between PPD and the blood level 238 cytokine concentration of CRP and IL-6 although these were not significant after adjusting for 239 possible confounders. The strong correlation between pathogenic members of the periodontal 240 biofilm and IL-1β cytokine levels suggests that a more targeted focus on specific members of 241 periodontal pocket biofilms and their relationship to the immune response could more directly 242 connect periodontal disease and heart health. 243 The positive correlation between the periodontal pathogens and high IL-1ß is consistent 257 with the apparent role of this cytokine in PD. IL-1ß is known to play a critical role in stimulating 258 bone resorption in the later stages of periodontal disease (25,26) (bone loss through resorption 259 happens in the final stages of severe periodontitis) and a study of adults with periodontal disease 260 found higher average concentration of IL-1ß in patients with severe periodontal disease than in 261 those with a healthy periodontium (27) Bivariate analysis determined that, of the four pathogens, the relative abundance of F. 272 nucleatum had the strongest relationship to blood serum IL-1ß levels (Table 3) . This is congruent 273 with previous research on periodontal disease which specifically identified F. nucleatum as a 274 strong stimulator of neutrophil secretion of IL-1ß (32,33). Our results, in combination with the 275 animal model studies and the periodontal research, indicate this organism contributes to both 276 periodontal disease and inflammatory processes associated with vascular dysfunction. 277 278 A weak correlation was detected between blood cholesterol (CHOL) levels and total 284 relative periodontal pathogen abundance, but the adjusted p-value was not significant (Table 4) . 285
No significant correlations were found with other blood lipid profiles. These results agree with a 286 case-control study which evaluated the relationship between periodontitis and serum lipid profile 287 in 60 patients, 30 with and 30 without chronic periodontitis (34). Blood serum levels of total 288 cholesterol, triglycerides (TRI), HDL and LDL were measured in both groups and there was no 289 significant difference in any measure of blood serum lipid concentration. 290 291 Table 5 shows the relationship between direct LDF vascular function measurements and 299 total relative abundance of periodontal pathogens. A strong and significant relationship was 300 found between total relative pathogen abundance and LDF measures of blood flow volume after 301 10 minutes of Sodium Nitroprusside (SNP) treatment (p=0.0005). The SNP10 value is an 302 estimate of the total number of blood cells passing between two points 10 minutes after SNP 303 treatment. The values after 1 minute and 5 minutes were also negatively correlated (data not 304 shown). Interestingly, there was no correlation with Acetylcholine (Ach) treatment. We are not 305 clear why this did not mirror the SNP result, though we note that Ach stimulates the release of 306 endogenous nitric oxide, while SNP is based on the addition of an exogenous nitric oxide source. 307
Although any given measure of vascular function is not without controversy, our data are 308 consistent with a relationship of relative periodontal pathogen load and poorer vascular function. 309 310 Metagenomics analysis also allows the opportunity to investigate the gene functional 320 diversity of microbial communities per se, and the relationship of gene functional pathways to 321 inflammation or disease. Given the strong association of total relative pathogen abundance to IL-322 1ß levels, we asked whether the abundances of any given gene pathway differed significantly 323 between the periodontal pocket microbiomes of individuals with high IL-1ß levels and those 324 with low IL-1ß levels. atherosclerotic heart disease. While the connections appear robust, the sample size of our study is 360 relatively modest. With the decrease in costs associated with high-throughput sequencing and 361 cytokine analyses, much larger studies will be possible. Also, a study over a longer timeframe 362 should allow greater opportunity for resolution of periodontitis and subsequent changes in 363 measures of CVD. In the future, larger studies should be carried out with a full panel of 364 metagenomics, serum and gingival crevicular cytokine analyses and CVD measurements over a 365 longer time frame. These findings establish a clear relationship between the periodontal 366 pathogen F. nucleatum and IL-1β, which has been shown to contribute significantly to heart 367 disease. This study was conducted in adults under age 40 and suggests that decades of exposure 368 to inflammatory cytokines contributes to life-threatening heart disease. Further study is needed to 369
show that heart disease progression can be delayed with appropriate oral hygiene. 370 371 Acknowledgements 372 373
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